-
Electronic (PDF)
-
Site License
-
Enterprisewide
Endovasc, Inc. Product Pipeline Analysis
Global Markets Direct, January 2009, Pages: 16
Endovasc, Inc. Product Pipeline Analysis
Summary
This report is an insightful source for data, analysis and strategic insights into a Scope’s pipeline and investigational products. The report also provides details on clinical trials covering trial phase, description, investigator information, primary and secondary end-points and trial results for products in development.
Scope
- Details of development stage by sector and equipment type.
- Pipeline products grouped by therapy area, development stage and trial phase.
- Detailed information on clinical trials covering trial phase, description, investigator .nformation, primary and secondary end-points and trial results.
- Trial updates, trial start and end dates, patient numbers and the trials primary outcome measures, secondary outcome measures.
- Product updates covering estimated approval dates and estimated launch dates.
- Descriptions of novel technologies relating to pipeline products of the company.
- Patents and patent applications covered for the product.
- News updates on key events relating to the product and its development.
Reasons to buy
- A single source to fulfill competitor information relating to products in development.
- Identify pipeline products that are potential competitor to your product lines.
- Understand a companys strategic position by accessing detailed independent intelligence on its product pipeline.
- Access clinical trial information to map trial results and plan targeted marketing activities.
- Take corrective measures on your own development programs and R&D initiatives based on regulatory events of competitor product pipelines.
- Identification of potential investment opportunities.
- Build up knowledge base for potential distribution and marketing partners.
- Helps avoid patent infringement.
- Timelines from concept to market lets you keep track of market potential build for a new product.
- Assess a companys future growth by determining its pipeline depth, for probable acquisition opportunities.
1
1 2
1.1 List of Tables 4
1.2 List of Figures 5
2 Company Snapshot 6
2.1 Key Information 6
2.2 Company Overview 6
3 Endovasc, Inc. Pipeline Products 7
3.1 Endovasc, Inc. Product Pipeline Analysis 7
3.1.1 Endovasc, Inc. Pipeline Products By Equipment Type 7
3.1.2 Endovasc, Inc. Pipeline Products By Development Stage 8
3.1.3 Endovasc, Inc. Pipeline Products By Therapy Area 9
3.1.4 Endovasc, Inc. Pipeline Products By News Summary 10
3.2 PROStent 10
3.2.1 Product Status 10
3.2.2 Product Description 10
3.2.3 Product Milestone 10
3.3 Biodegradable Vascular Stents 11
3.3.1 Product Status 11
3.3.2 Product Description 11
3.4 Biodegradable Ureteral Stent 11
3.4.1 Product Status 11
3.4.2 Product Description 12
3.5 Biodegradable Prostatic Stent 12
3.5.1 Product Status 12
3.5.2 Product Description 12
4 Recent Developments 13
4.1 Product News 13
4.1.1 Oct 18, 2004: New Endovasc Subsidary To Showcase ProStent technology 13
5 Appendix 14
5.1 Methodology 14
5.1.1 Coverage 14
5.1.2 Secondary Research 15
5.1.3 Primary Research 15
5.1.4 Expert Panel Validation 16
5.2 Contact Us 16
5.3 About us16
5.4 Disclaimer 16
Executive Summary
1.2 List of Figures
Figure 1: Endovasc, Inc. Pipeline Products By Development Stage 8
Figure 2: Global Markets Direct Methodology 14
The following companies are the major competitors of Endovasc, Inc.:
Anesiva, Inc.
Boston Scientific Corporation
Cook Group Incorporated
Cordis Corporation
Eli Lilly & Co
Guidant Corporation
Medtronic, Inc.
Customers who bought this item also bought
All rights reserved. © Copyright 2013 Research and Markets WWW6
Terms and Conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network
